BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005639/en/ Dr. Philip Ma is Chief Executive Officer, President, and Founder of PrognomiQ (Photo: Business... Read more
Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used by 87 percent of... Read more
Peabody, MA – JEOL USA is proud to announce the next generation of JEOL NMR spectrometers: the ECZ Luminous series. This product is a next step in spectrometer miniaturization and improving performance through state-of-the-art digital and high-frequency technologies. JEOL USA is a subsidiary of JEOL ltd, a well-respected manufacturer of cutting-edge scientific equipment with more... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announces new capabilities for its benchtop Fourier transform (FT) nuclear magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special lab infrastructure or cryogens, and offers excellent 1H sensitivity of 200:1 for gradient spectroscopy proton probes. A new adjustable temperature option increases experimental flexibility, while... Read more